Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 57.

Visentin, M; van Rosmalen, B V; Hiller, C; Bieze, M; Hofstetter, L; Verheij, J; Kullak-Ublick, G A; Koepsell, H; Phoa, S S; Tamai, I; Bennink, R J; van Gulik, T M; Stieger, B (2017). Impact of organic cation transporters (OCT-SLC22A) on differential diagnosis of intrahepatic lesions. Drug Metabolism and Disposition, 45(2):166-173.

Stieger, B; Kullak-Ublick, G A (2015). Transporters in the liver. In: Urban, L; Patel, V F; Vaz, R J. Antitargets and Drug Safety. KGaA, Weinheim: Wiley-VCH Verlag GmbH & Co., 159-171.

Eloranta, J J; Stieger, B; Kullak-Ublick, G A (2014). Bile salt transporters. In: You, G; Morris, M E. Drug Transporters: Molecular Characterization and Role in Drug Disposition. Hoboken, New Jersey: Wiley Series in Drug Discovery and Development, John Wiley & Sons Inc.., 127-139.

Hillgren, K M; Keppler, D; Zur, A A; Giacomini, K M; Stieger, B; Cass, C E; Zhang, L (2013). Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clinical Pharmacology and Therapeutics, 94(1):52-63.

Brouwer, K L R; Keppler, D; Hoffmaster, K A; Bow, D A J; Cheng, Y; Lai, Y; Palm, J E; Stieger, B; Evers, R (2013). In vitro methods to support transporter evaluation in drug discovery and development. Clinical Pharmacology and Therapeutics, 94(1):95-112.

Baur, K; Mertens, J C; Schmitt, J; Iwata, R; Stieger, B; Eloranta, J J; Frei, P; Stickel, F; Dill, M T; Seifert, Burkhardt; Bischoff Ferrari, H A; von Eckardstein, A; Bochud, P Y; Müllhaupt, B; Geier, A (2012). Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver International, 32(4):635-643.

Stieger, B; Heger, M; de Graaf, W; Paumgartner, G; van Gulik, T (2012). The emerging role of transport systems in liver function tests. European Journal of Pharmacology, 675(1-3):1-5.

Iwata, R; Baur, K; Stieger, B; Mertens, J C; Daly, A K; Frei, P; Braun, J; Vergopoulos, A; Stickel, F; Sabrane, K; Martin, I V; Schmitt, J; Goetze, O; Day, C P; Müllhaupt, B; Geier, A (2011). A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clinical Science, 120(7):287-296.

Svoboda, M; Wlcek, K; Taferner, B; Hering, S; Stieger, B; Tong, D; Zeillinger, R; Thalhammer, T; Jäger, W (2011). Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Biomedicine & pharmacotherapy, 65(6):417-426.

Stieger, B; Geier, A (2011). Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opinion on Drug Metabolism & Toxicology, 7(4):411-425.

Millet, P; Moulin, M; Stieger, B; Daali, Y; Pastor, C M (2011). How organic anions accumulate in hepatocytes lacking mrp2: evidence in rat liver. Journal of Pharmacology and Experimental Therapeutics, 336(3):624-632.

Guyot, C; Stieger, B (2011). Interaction of bile salts with rat canalicular membrane vesicles: Evidence for bile salt resistant microdomains. Journal of Hepatology, 55(6):1368-1376.

Stieger, B; Meier, P J (2011). Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics, 12(5):611-631.

Le Vee, M; Jouan, E; Stieger, B; Lecureur, V; Fardel, O (2011). Regulation of drug transporter expression by oncostatin M in human hepatocytes. Biochemical Pharmacology, 82(3):304-311.

Stieger, B (2011). Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: A metabolic link between liver and kidney? Journal of Hepatology, 54(3):406-407.

De Bruyn, T; Fattah, S; Stieger, B; Augustijns, P; Annaert, P (2011). Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3. Journal of Pharmaceutical Sciences, 100(11):5018-5030.

Stieger, B (2011). The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation. Handbook of Experimental Pharmacology, (201):205-259.

Stieger, B; Beuers, U (2011). The canalicular bile salt export pump BSEP (ABCB11) as a potential therapeutic target. Current Drug Targets, 12(5):661-670.

Chan, S Y; Martín-Santos, A; Loubière, L S; González, A M; Stieger, B; Logan, A; McCabe, C J; Franklyn, J A; Kilby, M D (2011). The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation. Journal of Physiology, 589(Pt 11):2827-2845.

Iwata, R; Stieger, B; Mertens, J C; Müller, T; Baur, K; Frei, P; Braun, J; Vergopoulos, A; Martin, I V; Schmitt, J; Goetze, O; Bibert, S; Bochud, P Y; Müllhaupt, B; Berg, T; Geier, A (2011). The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. Journal of Viral Hepatitis, 18(11):768-778.

de Graaf, W; Häusler, S; Heger, M; van Ginhoven, T M; van Cappellen, G; Bennink, R J; Kullak-Ublick, G A; Hesselmann, R; van Gulik, T M; Stieger, B (2011). Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. Journal of Hepatology, 54(4):738-745.

de Waart, D R; Häusler, S; Vlaming, M L H; Kunne, C; Hänggi, E; Gruss, H-J; Oude Elferink, R P J; Stieger, B (2010). Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein. Journal of Pharmacology and Experimental Therapeutics, 334(1):78-86.

Schürch, R; Todesco, L; Novakova, K; Mevissen, M; Stieger, B; Krähenbühl, S (2010). The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats. European Journal of Pharmacology, 635(1-3):171-176.

Davit-Spraul, A; Fabre, M; Branchereau, S; Baussan, C; Gonzales, E; Stieger, B; Bernard, O; Jacquemin, E (2010). ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology, 51(5):1645-1655.

Martin, I V; Schmitt, J; Minkenberg, A; Mertens, J C; Stieger, B; Mullhaupt, B; Geier, A (2010). Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biological Chemistry, 391(12):1441-1449.

Loubière, L S; Vasilopoulou, E; Bulmer, J N; Taylor, P M; Stieger, B; Verrey, F; McCabe, C J; Franklyn, J A; Kilby, M D; Chan, S-Y (2010). Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta, 31(4):295-304.

Peters, S; Egert, A; Stieger, B; Keller, F (2010). Functional identification of Arabidopsis ATSIP2 (At3g57520) as an alkaline α-galactosidase with a substrate specificity for raffinose and an apparent sink-specific expression patter. Plant & Cell Physiology, 51(10):1815-1819.

Hajda, J; Rentsch, K M; Gubler, C; Steinert, H; Stieger, B; Fattinger, K (2010). Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. European Journal of Pharmaceutical Sciences, 41(5):729-735.

Annaert, P; Ye, Z W; Stieger, B; Augustijns, P (2010). Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica, 40(3):163-176.

Maggiore, G; Gonzales, E; Sciveres, M; Redon, M-J; Grosse, B; Stieger, B; Davit-Spraul, A; Fabre, M; Jacquemin, E (2010). Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. Journal of Hepatology, 53(5):981-986.

Stieger, B (2010). Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metabolism Reviews, 42(3):437-445.

Klein, K; Jungst, C; Mwinyi, J; Stieger, B; Krempler, F; Patsch, W; Eloranta, J J; Kullak-Ublick, G A (2010). The Human Organic Anion Transporter Genes OAT5 and OAT7 Are Transactivated by Hepatocyte Nuclear Factor-1{alpha} (HNF-1{alpha}). Molecular Pharmacology, 78(6):1079-1087.

Eloranta, J J; Hiller, C; Hausler, S; Stieger, B; Kullak-Ublick, G A (2009). Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Molecular Pharmacology, 76(5):1062-1071.

Stieger, B (2009). Recent insights into the function and regulation of the bile salt export pump (ABCB11). Current Opinion in Lipidology, 20(3):176-181.

Stieger, B; Ismair, M G; Guyot, C; Synal-Hermanns, U; Kullak-Ublick, G A (2009). Canalicular microdomains and bile formation. In: Keppler, D; Beuers, U; Stiehl, A; Trauner, M. Bile Acid Biology and Therapeutic Actions. Dordrecht, NL: Springer, 31-35.

Ismair, M G; Häusler, S; Stuermer, C A; Guyot, C; Meier, P J; Roth, J; Stieger, B (2009). ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes. Hepatology, 49(5):1673-1682.

Stieger, B; Arand, M (2009). Biotransformation und Detoxifizierung in der Leber. In: Schartl, M; Gessler, M; von Eckardstein, A. Biochemie und Molekularbiologie des Menschen. München: Urban und Fischer, 845-859.

Le Vee, M; Lecureur, V; Moreau, A; Stieger, B; Fardel, O (2009). Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes. Drug Metabolism and Disposition, 37(11):2228-2235.

Corti, N; Heck, A; Rentsch, K; Zingg, W; Jetter, A; Stieger, B; Pauli-Magnus, C (2009). Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers. European Journal of Clinical Pharmacology, 65(10):999-1006.

Leuthold, S; Hagenbuch, B; Mohebbi, N; Wagner, C A; Meier, P J; Stieger, B (2009). Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. American Journal of Physiology. Cell Physiology, 296(3):C570-C582.

Vee, M L; Lecureur, V; Stieger, B; Fardel, O (2009). Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metabolism and Disposition, 37(3):685-693.

Stieger, B (2008). Turning over or turning around: hepatic phosphatidylcholine in the mouse model for progressive familial intrahepatic cholestasis type 3. Liver International, 28(7):908-910.

Zaïr, Z M; Eloranta, J J; Stieger, B; Kullak-Ublick, G A (2008). Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics, 9(5):597-624.

Strautnieks, S S; Byrne, J A; Pawlikowska, L; Cebecauerova, D; Rayner, A; Dutton, L; Meier, Y; Antoniou, A; Stieger, B; Arnell, H; Ozcay, F; Al-Hussaini, H F; Bassas, A F; Verkade, H J; Fischler, B; Nemeth, A; Kotalova, R; Shneider, B L; Cielecka-Kuszyk, J; McClean, P; Whitington, P F; Sokal, E; Jirsa, M; Wali, S H; Jankowska, I; Pawlowska, J; Mieli-Vergani, G; Knisely, A S; Buli, L N; Thompson, R J (2008). Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology, 134(4):1203-1214.

Le Vee, M; Gripon, P; Stieger, B; Fardel, O (2008). Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metabolism and Disposition, 36(2):217-222.

Meier, Y; Zodan, T; Lang, C; Zimmermann, R; Kullak-Ublick, G A; Meier, P J; Stieger, B; Pauli-Magnus, C (2008). Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World Journal of Gastroenterology, 14(1):38-45.

Hoekstra, H; Tian, Y; Jochum, W; Stieger, B; Graf, R; Porte, R J; Clavien, P A (2008). Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation, 85(8):1159-1166.

Gui, C; Miao, Y; Thompson, L; Wahlgren, B; Mock, M; Stieger, B; Hagenbuch, B (2008). Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. European Journal of Pharmacology, 584(1):57-65.

Todesco, L; Bur, D; Brooks, H; Török, M; Landmann, L; Stieger, B; Krähenbühl, S (2008). Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2. Cellular and Molecular Life Sciences, 65(10):1596-1608.

Biber, J; Stieger, B; Stange, G; Murer, H (2007). Isolation of renal proximal tubular brush-border membranes. Nature Protocols, 2(6):1356-1359.

Frei, P; Gao, B; Hagenbuch, B; Mate, A; Biber, J; Murer, H; Meier, P J; Stieger, B (2005). Identification and localization of sodium-phosphate cotransporters in hepatocytes and cholangiocytes of rat liver. American Journal of Physiology: Gastrointestinal and Liver Physiology, 288(4):G771-G778.

Cattori, V; van Montfoort, J E; Stieger, B; Landmann, L; Meijer, D K; Winterhalter, K H; Meier, P J; Hagenbuch, B (2001). Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflügers Archiv: European Journal of Physiology (Pflugers Archiv), 443(2):188-195.

Hagenbuch, N; Reichel, C; Stieger, B; Cattori, V; Fattinger, K E; Landmann, L; Meier, P J; Kullak-Ublick, G A (2001). Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. Journal of Hepatology, 34(6):881-887.

Ismair, M G; Stieger, B; Cattori, V; Hagenbuch, B; Fried, M; Meier, P J; Kullak-Ublick, G A (2001). Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology, 121(5):1185-1190.

Cattori, V; Hagenbuch, B; Hagenbuch, N; Stieger, B; Ha, R; Winterhalter, K E; Meier, P J (2000). Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver. FEBS Letters, 474(2-3):242-245.

Fattinger, K; Cattori, V; Hagenbuch, B; Meier, P J; Stieger, B (2000). Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Hepatology, 32(1):82-86.

Reichel, C; Gao, B; Van Montfoort, J; Cattori, V; Rahner, C; Hagenbuch, B; Stieger, B; Kamisako, T; Meier, P J (1999). Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology, 117(3):688-695.

This list was generated on Sat Dec 16 17:11:38 2017 CET.